Guardant Health(us:GH)
42.02
-3.38%
Updated on 2025-04-03
Open:41.00
Close:42.02
High:42.44
Low:40.22
Prev Close:43.49
Volume:1.38M
Turnover:57.61M
Turnover Ratio:1.12%
Shares:123.42M
MarketCap:5.19B
Total 3 records
| code | change | total | increase | decrease | rps5 | rps10 | rps15 | rps20 |
|---|---|---|---|---|---|---|---|---|
Diagnostics & Research BK2011 | -3.75% | 57 | 5 | 50 | 48 | 39 | 36 | 33 |
ARK Portfolio BK2153 | -6.57% | 172 | 7 | 164 | 29 | 63 | 46 | 38 |
AI medical concept stocks BK23592 | -2.98% | 29 | 1 | 29 | 70 | 72 | 71 | 54 |
About
Guardant Health, Inc. is a precision oncology company engaged in the treatment of cancer through the use of proprietary blood-based tests, vast data sets, and advanced analytics. Its solutions include treatment selection, recurrence detection, and early detection. The company was founded by Helmy Eltoukhy, AmirAli H. Talasaz, and Michael Joseph Wiley in 2011 and is headquartered in Palo Alto, CA.
Address:3100 Hanover Street
Website:http://www.guardanthealth.com
Market Movers